Which should go first during same-day bidirectional endosocopy with propofol sedation?

Yu Hsi Hsieh, Hwai Jeng Lin, Kuo Chih Tseng

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background and Aim: Same-day bidirectional endoscopy, including esophagogastroduodenoscopy (EGD) and colonoscopy, is frequently performed to screen for cancer and gastrointestinal bleeding. However, the optimal sequence for the procedures is unclear thus far. The aim of this study was to evaluate the optimal sequence for same-day bidirectional endoscopy. Methods: Consecutive patients undergoing same-day bidirectional endoscopy under propofol sedation were randomized to either the colonoscopy-first group (colonoscopy followed by EGD, n=87) or the EGD-first group (EGD followed by colonoscopy, n=89). We evaluated the propofol dose, procedure duration, patient tolerance and recovery, adverse events, and endoscopic findings. The patient tolerance was assessed with a 0-10 visual analog scale. Results: Total procedure times, patients' tolerance and recovery, adverse events, and endoscopic findings were similar between the two groups. The total propofol dose was significantly higher for the colonoscopy-first group than for the EGD-first group (mean 95% credibility limit: 135.7 [70-201.4]mg vs 124.7 [64.1-185.3]mg, respectively, P=0.024). Patients in the colonoscopy-first group moved significantly more during colonoscopy than those in the EGD-first group: 1.1 (0-3.8) versus 0.6 (0-2.9) scores, respectively (P=0.024). Conclusion: The optimal sequence for same-day bidirectional endoscopy is EGD followed by colonoscopy. In this order, the procedure is better tolerated, and patients require a lower overall dose of propofol.

Original languageEnglish
Pages (from-to)1559-1564
Number of pages6
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume26
Issue number10
DOIs
Publication statusPublished - 2011

Fingerprint

Digestive System Endoscopy
Propofol
Colonoscopy
Endoscopy
Gastrointestinal Neoplasms
Visual Analog Scale
Hemorrhage

Keywords

  • Colonoscopy
  • Esophagogastroduodenoscopy
  • Propofol

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Which should go first during same-day bidirectional endosocopy with propofol sedation? / Hsieh, Yu Hsi; Lin, Hwai Jeng; Tseng, Kuo Chih.

In: Journal of Gastroenterology and Hepatology (Australia), Vol. 26, No. 10, 2011, p. 1559-1564.

Research output: Contribution to journalArticle

@article{3a8dbec94fc9464899eebdef89ad4ab8,
title = "Which should go first during same-day bidirectional endosocopy with propofol sedation?",
abstract = "Background and Aim: Same-day bidirectional endoscopy, including esophagogastroduodenoscopy (EGD) and colonoscopy, is frequently performed to screen for cancer and gastrointestinal bleeding. However, the optimal sequence for the procedures is unclear thus far. The aim of this study was to evaluate the optimal sequence for same-day bidirectional endoscopy. Methods: Consecutive patients undergoing same-day bidirectional endoscopy under propofol sedation were randomized to either the colonoscopy-first group (colonoscopy followed by EGD, n=87) or the EGD-first group (EGD followed by colonoscopy, n=89). We evaluated the propofol dose, procedure duration, patient tolerance and recovery, adverse events, and endoscopic findings. The patient tolerance was assessed with a 0-10 visual analog scale. Results: Total procedure times, patients' tolerance and recovery, adverse events, and endoscopic findings were similar between the two groups. The total propofol dose was significantly higher for the colonoscopy-first group than for the EGD-first group (mean 95{\%} credibility limit: 135.7 [70-201.4]mg vs 124.7 [64.1-185.3]mg, respectively, P=0.024). Patients in the colonoscopy-first group moved significantly more during colonoscopy than those in the EGD-first group: 1.1 (0-3.8) versus 0.6 (0-2.9) scores, respectively (P=0.024). Conclusion: The optimal sequence for same-day bidirectional endoscopy is EGD followed by colonoscopy. In this order, the procedure is better tolerated, and patients require a lower overall dose of propofol.",
keywords = "Colonoscopy, Esophagogastroduodenoscopy, Propofol",
author = "Hsieh, {Yu Hsi} and Lin, {Hwai Jeng} and Tseng, {Kuo Chih}",
year = "2011",
doi = "10.1111/j.1440-1746.2011.06786.x",
language = "English",
volume = "26",
pages = "1559--1564",
journal = "Journal of Gastroenterology and Hepatology (Australia)",
issn = "0815-9319",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - Which should go first during same-day bidirectional endosocopy with propofol sedation?

AU - Hsieh, Yu Hsi

AU - Lin, Hwai Jeng

AU - Tseng, Kuo Chih

PY - 2011

Y1 - 2011

N2 - Background and Aim: Same-day bidirectional endoscopy, including esophagogastroduodenoscopy (EGD) and colonoscopy, is frequently performed to screen for cancer and gastrointestinal bleeding. However, the optimal sequence for the procedures is unclear thus far. The aim of this study was to evaluate the optimal sequence for same-day bidirectional endoscopy. Methods: Consecutive patients undergoing same-day bidirectional endoscopy under propofol sedation were randomized to either the colonoscopy-first group (colonoscopy followed by EGD, n=87) or the EGD-first group (EGD followed by colonoscopy, n=89). We evaluated the propofol dose, procedure duration, patient tolerance and recovery, adverse events, and endoscopic findings. The patient tolerance was assessed with a 0-10 visual analog scale. Results: Total procedure times, patients' tolerance and recovery, adverse events, and endoscopic findings were similar between the two groups. The total propofol dose was significantly higher for the colonoscopy-first group than for the EGD-first group (mean 95% credibility limit: 135.7 [70-201.4]mg vs 124.7 [64.1-185.3]mg, respectively, P=0.024). Patients in the colonoscopy-first group moved significantly more during colonoscopy than those in the EGD-first group: 1.1 (0-3.8) versus 0.6 (0-2.9) scores, respectively (P=0.024). Conclusion: The optimal sequence for same-day bidirectional endoscopy is EGD followed by colonoscopy. In this order, the procedure is better tolerated, and patients require a lower overall dose of propofol.

AB - Background and Aim: Same-day bidirectional endoscopy, including esophagogastroduodenoscopy (EGD) and colonoscopy, is frequently performed to screen for cancer and gastrointestinal bleeding. However, the optimal sequence for the procedures is unclear thus far. The aim of this study was to evaluate the optimal sequence for same-day bidirectional endoscopy. Methods: Consecutive patients undergoing same-day bidirectional endoscopy under propofol sedation were randomized to either the colonoscopy-first group (colonoscopy followed by EGD, n=87) or the EGD-first group (EGD followed by colonoscopy, n=89). We evaluated the propofol dose, procedure duration, patient tolerance and recovery, adverse events, and endoscopic findings. The patient tolerance was assessed with a 0-10 visual analog scale. Results: Total procedure times, patients' tolerance and recovery, adverse events, and endoscopic findings were similar between the two groups. The total propofol dose was significantly higher for the colonoscopy-first group than for the EGD-first group (mean 95% credibility limit: 135.7 [70-201.4]mg vs 124.7 [64.1-185.3]mg, respectively, P=0.024). Patients in the colonoscopy-first group moved significantly more during colonoscopy than those in the EGD-first group: 1.1 (0-3.8) versus 0.6 (0-2.9) scores, respectively (P=0.024). Conclusion: The optimal sequence for same-day bidirectional endoscopy is EGD followed by colonoscopy. In this order, the procedure is better tolerated, and patients require a lower overall dose of propofol.

KW - Colonoscopy

KW - Esophagogastroduodenoscopy

KW - Propofol

UR - http://www.scopus.com/inward/record.url?scp=80053121149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053121149&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1746.2011.06786.x

DO - 10.1111/j.1440-1746.2011.06786.x

M3 - Article

VL - 26

SP - 1559

EP - 1564

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - 10

ER -